HuGE Literature Finder
Records 1-30
|
Association between CYP2C19 polymorphisms and clinical outcomes in patients undergoing stent procedure for cerebral artery stenosis.
Scientific reports 2021 Mar 11 (1): 5974. Li Yan-Jiao, Chen Xuan, Tao Li-Na, Hu Xin-Yuan, Wang Xin-Lu, Song Yan-Qi |
|
Impact of genetic variants on clinical outcome after percutaneous coronary intervention in elderly patients.
Aging 2021 Mar 13 (5): 6506-6524. Cha Jung-Joon, Park Jae Hyoung, Joo Hyung Joon, Hong Soon Jun, Ahn Tae Hoon, Kim Byeong-Keuk, Shin WonYong, Ahn Sung Gyun, Yoon JungHan, Kim Yong Hoon, Cho Yun-Hyeong, Kang Woong Chol, Kim Weon, Lim Young-Hyo, Gwon Hyeon Cheol, Choi Woong Gil, Lim Do-S |
|
Association of FMO3 rs1736557 polymorphism with clopidogrel response in Chinese patients with coronary artery disease.
European journal of clinical pharmacology 2020 Oct . Zhu Kong-Xiang, Song Pei-Yuan, He-Li , Li Mu-Peng, Du Yin-Xiao, Ma Qi-Lin, Peng Li-Ming, Chen Xiao-Pi |
|
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial.
JAMA 2020 08 324 (8): 761-771. Pereira Naveen L, Farkouh Michael E, So Derek, Lennon Ryan, Geller Nancy, Mathew Verghese, Bell Malcolm, Bae Jang-Ho, Jeong Myung Ho, Chavez Ivan, Gordon Paul, Abbott J Dawn, Cagin Charles, Baudhuin Linnea, Fu Yi-Ping, Goodman Shaun G, Hasan Ahmed, Iturriaga Erin, Lerman Amir, Sidhu Mandeep, Tanguay Jean-Francois, Wang Liewei, Weinshilboum Richard, Welsh Robert, Rosenberg Yves, Bailey Kent, Rihal Charanj |
|
CYP2C19 genotype and adverse cardiovascular outcomes after stent implantation in clopidogrel-treated Asian populations: A systematic review and meta-analysis.
Platelets 2019 30 (2): 229-240. Xi Ziwei, Fang Fang, Wang Jiayang, AlHelal Jumana, Zhou Yujie, Liu W |
|
CRISPLD1 rs12115090 polymorphisms alters antiplatelet potency of clopidogrel in coronary artery disease patients in Chinese Han.
Gene 2018 Aug . Wang Jie-Ya, Zhang Yan-Jiao, Li He, Hu Xiao-Lei, Li Mu-Peng, Song Pei-Yuan, Ma Qi-Lin, Peng Li-Ming, Chen Xiao-Pi |
|
Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention.
Cardiovascular toxicology 2018 May . Mahdieh Nejat, Rabbani Ahmad, Firouzi Ata, Zahedmehr Ali, Hoseinimoghaddam Maryam, Saeidi Sedigheh, Sanati Hamidreza, Basiri Hosseinali, Noohi Feridoun, Rabbani Bahareh, Maleki Maj |
|
Gene polymorphisms in dual antiplatelet therapy and the presence of hypo-attenuated leaflet thickening after transcatheter aortic valve replacement.
Journal of thrombosis and thrombolysis 2018 Feb . Xiong Tian-Yuan, Liao Yan-Biao, Feng Yuan, Zhao Ming-Yue, Zhao Zhen-Gang, Li Yi-Jian, Liu Xiao-Jing, Chen M |
|
Integrative medicine on optimizing clopidogrel and aspirin therapy.
Chinese journal of integrative medicine 2018 Jan . Chen H |
|
The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.
Basic & clinical pharmacology & toxicology 2017 Jan . Saydam Faruk, De?irmenci ?rfan, Birdane Alparslan, Özdemir Mahmut, Ulus Taner, Özbayer Cansu, Çolak Ertu?rul, Ata Necmi, Güne? Hasan Vey |
|
CYP2C19 genotyping combined with on-clopidogrel platelet reactivity in predicting major adverse cardiovascular events in Chinese patients with percutaneous coronary intervention.
Thrombosis research 2016 Oct 147 108-114. Tang Xiao-Fang, Han Ya-Ling, Zhang Jia-Hui, Wang Jing, Yao Yi, He Chen, Xu Bo, Gao Zhan, Qiao Shu-Bin, Chen Jue, Wu Yuan, Chen Ji-Lin, Gao Run-Lin, Yang Yue-Jin, Yuan Jin-Qi |
|
Gene polymorphism of CYP2C19*2, *3 and CYP3A4*1B and early stent thrombosis: case reports and literature review.
Personalized medicine 2016 Sep 13 (5): 423-428. Kulmyrzaeva Nazgul, Tatarunas Vacis, Skipskis Vilius, Smagulova Gaziza, Seitmaganbetova Nazgul, Veikutiene Audrone, Lesauskaite Vai |
|
CYP2C19 loss-of-function alleles are not associated with clinical outcome of clopidogrel therapy in patients treated with newer-generation drug-eluting stents.
Medicine 2016 Jun 95 (26): e4049. Choi Ik Jun, Koh Yoon-Seok, Park Mahn-Won, Her Sung Ho, Choi Yun-Seok, Park Chul-Soo, Park Hun-Jun, Kim Pum-Joon, Chung Wook-Sung, Kim Ho-Sook, Shin Jae-Gook, Seung Ki-Bae, Chang Kiy |
|
Simultaneous subacute coronary artery stent thrombosis in a carrier of two CYP2C19 loss-of function polymorphisms (*2/*3).
International journal of cardiology 2016 Jun 212 148-50. Chikata Yuichi, Iwata Hiroshi, Osborn Eric A, Fukuda Kentaro, Okai Iwao, Shiozaki Masayuki, Kimura Yuki, Inoue Kenji, Fujiwara Yasumasa, Sumiyoshi Masata |
|
Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke.
Acta pharmacologica Sinica 2016 May . Liu Rui, Zhou Zi-Yi, Chen Yi-Bei, Li Jia-Li, Yu Wei-Bang, Chen Xin-Meng, Zhao Min, Zhao Yuan-Qi, Cai Ye-Feng, Jin Jing, Huang M |
|
Cytochrome allelic variants and clopidogrel metabolism in cardiovascular diseases therapy.
Molecular biology reports 2016 Apr . Jarrar Mohammed, Behl Shalini, Manyam Ganiraju, Ganah Hany, Nazir Mohammed, Nasab Reem, Moustafa Khal |
|
Evaluation of clopidogrel response variability and identification of the CYP2C19 polymorphism in Mexican patients.
Archivos de cardiologia de Mexico 2016 Mar . Viveros Martha Eva, Areán Carlos, Gutiérrez Sergio, Vázquez Soledad, Cardiel Mario Humberto, Taboada Alejandra, Marín Gissela, Solorio Ruben, García Nall |
|
Association between high on-treatment platelet reactivity and occurrence of cerebral ischemic events in patients undergoing percutaneous coronary intervention.
Thrombosis research 2016 Feb 138 49-54. Komosa A, Siller-Matula J M, Lesiak M, Michalak M, Kowal J, M?czy?ski M, Siniawski A, Mularek-Kubzdela T, Wi?niewski S, Grajek |
|
Effects of genetic factors to stent thrombosis due to clopidogrel resistance after coronary stent placement.
Cellular and molecular biology (Noisy-le-Grand, France) 2016 62 (1): 51-5. Kirac D, Erdem A, Avcilar T, Yesilcimen K, Guney A I, Emre A, Yazici S, Terzi S, Kaspar E C, Cetin S E, Isbir |
|
Correlates of pre-hospital morphine use in ST-elevation myocardial infarction patients and its association with in-hospital outcomes and long-term mortality: the FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) programme.
European heart journal 2015 Nov . Puymirat Etienne, Lamhaut Lionel, Bonnet Nicolas, Aissaoui Nadia, Henry Patrick, Cayla Guillaume, Cattan Simon, Steg Gabriel, Mock Laurent, Ducrocq Gregory, Goldstein Patrick, Schiele François, Bonnefoy-Cudraz Eric, Simon Tabassome, Danchin Nicol |
|
Study design and rationale for optimal aNtiplatelet pharmacotherapy guided by bedSIDE genetic or functional TESTing in elective PCI patients (ONSIDE TEST): a prospective, open-label, randomized parallel-group multicenter trial (NCT01930773).
Kardiologia polska 2015 Sep . Ko?towski ?ukasz, Aradi Daniel, Huczek Zenon, Tomaniak Mariusz, Sibbing Dirk, Filipiak Krzysztof J, Kochman Janusz, Balsam Pawe?, Opolski Grzego |
|
Genetic testing and antiplatelet treatment: Still way to go?
International journal of cardiology 2015 May 187 63-5. Oikonomou Evangelos, Papageorgiou Nikolaos, Papaioannou Spyridon, Toutouzas Konstantinos, Latsios George, Siasos Gerasimos, Tousoulis Dimitr |
|
Genetic polymorphisms of CYP2C19 2 and ABCB1 C3435T affect the pharmacokinetic and pharmacodynamic responses to clopidogrel in 401 patients with acute coronary syndrome.
Gene 2015 Mar 558 (2): 200-7. Wang Xia-Qin, Shen Chen-Lin, Wang Bang-Ning, Huang Xiao-Hui, Hu Zhang-le, Li J |
|
Characterization of patients with angioscopically-detected in-stent mural thrombi – genetics of clopidogrel responsiveness and generations of drug-eluting stents.
Circulation journal : official journal of the Japanese Circulation Society 2015 79 (1): 85-90. Ichikawa Minoru, Takei Yoshizumi, Hamasaki Toshimitsu, Kijima Yoshiyu |
|
Cytochrome P450 CYP 2C19*2 Associated with Adverse 1-Year Cardiovascular Events in Patients with Acute Coronary Syndrome.
PloS one 2015 10 (7): e0132561. Wei You-Quan, Wang Dian-Gang, Yang Hao, Cao He |
|
Effect of clinical factors and gene polymorphism of CYP2C19*2, *17 and CYP4F2*3 on early stent thrombosis.
Pharmacogenomics 2015 16 (3): 181-9. Kupstyte Nora, Zaliunas Remigijus, Tatarunas Vacis, Skipskis Vilius, Zaliaduonyte-Peksiene Diana, Grabauskyte Ingrida, Dovidaitiene Dovile, Bumblauskas Karolis, Gustiene Olivija, Lesauskaite Vai |
|
CYP2C19 genotype has a greater effect on adverse cardiovascular outcomes following percutaneous coronary intervention and in Asian populations treated with clopidogrel: a meta-analysis.
Circulation. Cardiovascular genetics 2014 Dec 7 (6): 895-902. Sorich Michael J, Rowland Andrew, McKinnon Ross A, Wiese Michael |
|
Characterization of Patients With Angioscopically-Detected In-Stent Mural Thrombi.
Circulation journal : official journal of the Japanese Circulation Society 2014 Oct . Ichikawa Minoru, Takei Yoshizumi, Hamasaki Toshimitsu, Kijima Yoshiyu |
|
Effects of cytochrome P450 2C19 and paraoxonase 1 polymorphisms on antiplatelet response to clopidogrel therapy in patients with coronary artery disease.
PloS one 2014 9 (10): e110188. Tresukosol Damrus, Suktitipat Bhoom, Hunnangkul Saowalak, Kamkaew Ruttakarn, Poldee Saiphon, Tassaneetrithep Boonrat, Likidlilid At |
|
Clopidogrel response variability: impact of genetic polymorphism and platelet biomarkers for predicting adverse outcomes poststenting.
American journal of therapeutics 0 22 (3): 222-30. Golukhova Elena Z, Ryabinina Mariya N, Bulaeva Naida I, Grigorian Marina V, Kubova Maida Ch, Serebruany Victor |
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 15, 2021
- Content source: